ClinicalTrialsFinder
RecruitingNCT07659756

Global Healthcare Study on Atopic Dermatitis

Sponsor

Julia Tatjana Maul

Enrollment

9,600 participants

Start Date

Jan 1, 2025

Study Type

OBSERVATIONAL

Conditions

atopic dermatitis (eczema)Atopic Dermatitis (AD)

Summary

The Global Healthcare Study on Atopic Dermatitis (GHSAD) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with atopic dermatitis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery and outcomes across different healthcare systems.

Eligibility

Min Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with atopic dermatitis (ad) and atopic dermatitis (eczema). The study is currently recruiting participants at 1 location. People eligible for this study include aged 14 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

University of Zurich

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07659756

Related Trials

Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis

NCT075737351 location

A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)

NCT075448621 location

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT0729839523 locations

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

NCT0710548888 locations

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

NCT074555782 locations